{"DataElement":{"publicId":"3285192","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy Langerhans Cell Histiocytosis Status Type","preferredDefinition":"A description of the best response to therapy of Langerhans Cell Histiocytosis disease.","longName":"2946463v1.0:3284170v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2946463","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Having the most positive qualities._The result of therapy for a given disease or condition in a patient or group of patients.","longName":"2404658v1.0:3194600v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3194600","version":"1","preferredName":"Best Outcome of Therapy","preferredDefinition":"Having the most positive qualities.:The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C25432:C18919","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome of Therapy","conceptCode":"C18919","definition":"The result of therapy for a given disease or condition in a patient or group of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D80CD45-BE7A-5B19-E040-BB89AD430E80","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-02","modifiedBy":"ONEDATA","dateModified":"2011-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"747EBAC6-25E8-A734-E040-BB89AD43588E","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3284170","version":"1","preferredName":"Langerhans Cell Histiocytosis Status Type","preferredDefinition":"A neoplastic proliferation of Langerhans cells which contain Birbeck granules by ultrastructural examination.  Three major overlapping syndromes are recognized: eosinophilic granuloma, Letterer-Siwe disease, and Hand-Schuller-Christian disease.  The clinical course is generally related to the number of organs affected at presentation.  (WHO, 2001)_A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"3284170v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B13B9AEB-61FC-864B-E040-BB89AD43259A","beginDate":"2011-11-08","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-08","modifiedBy":"ONEDATA","dateModified":"2011-11-08","deletedIndicator":"No"},{"value":"Not evaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8BDC24-8936-D4D0-E040-BB89AD433258","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"Stable disease","valueDescription":"Stable disease","ValueMeaning":{"publicId":"3284172","version":"1","preferredName":"Stable disease","longName":"3284172","preferredDefinition":"Persistence of signs and/or symptoms of disease without appearance of new lesions.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8BDC24-8940-D4D0-E040-BB89AD433258","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8BDC24-8958-D4D0-E040-BB89AD433258","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"Partial response","valueDescription":"Partial response","ValueMeaning":{"publicId":"3284173","version":"1","preferredName":"Partial response","longName":"3284173","preferredDefinition":"Regression of signs and/or symptoms of disease without appearance of new lesions.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8BDC24-8962-D4D0-E040-BB89AD433258","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8BDC24-897A-D4D0-E040-BB89AD433258","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"Progressive disease","valueDescription":"Progressive disease","ValueMeaning":{"publicId":"3284174","version":"1","preferredName":"Progressive disease","longName":"3284174","preferredDefinition":"Progression of signs and/or symptoms of disease initially detected and/or reappearance of old and/or appearance of new lesions.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8BDC24-8984-D4D0-E040-BB89AD433258","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8BDC24-899C-D4D0-E040-BB89AD433258","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"Mixed response","valueDescription":"Mixed response","ValueMeaning":{"publicId":"3284175","version":"1","preferredName":"Mixed response","longName":"3284175","preferredDefinition":"Regression of some signs and/or symptoms of disease with appearance of new lesions.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8BDC24-89A6-D4D0-E040-BB89AD433258","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8BDC24-89BE-D4D0-E040-BB89AD433258","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"Complete response","valueDescription":"Complete response","ValueMeaning":{"publicId":"3284176","version":"1","preferredName":"Complete response","longName":"3284176","preferredDefinition":"Absence of all signs and/or symptoms of Langerhans cell histiocytosis.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8BDC24-89C8-D4D0-E040-BB89AD433258","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD8BDC24-89E0-D4D0-E040-BB89AD433258","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","deletedIndicator":"No"},{"value":"Unknown / not tested","valueDescription":"Unknown Or Not Done","ValueMeaning":{"publicId":"2970626","version":"1","preferredName":"Unknown Or Not Done","longName":"2970626","preferredDefinition":"Not known, not observed, not recorded, or refused.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Indicates a task, process or examination that has either not been initiated or completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AF4AF2B-2741-6A95-E040-BB89AD4369D7","latestVersionIndicator":"Yes","beginDate":"2009-12-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BA05F7-D51F-FD4E-E040-BB89AD436662","beginDate":"2011-11-08","endDate":null,"createdBy":"NYCHM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3284169","version":"1","preferredName":"Langerhans Cell Histiocytosis Status Type","preferredDefinition":"A neoplastic proliferation of Langerhans cells which contain Birbeck granules by ultrastructural examination.  Three major overlapping syndromes are recognized: eosinophilic granuloma, Letterer-Siwe disease, and Hand-Schuller-Christian disease.  The clinical course is generally related to the number of organs affected at presentation.  (WHO, 2001):A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C3107:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Langerhans Cell Histiocytosis","conceptCode":"C3107","definition":"A neoplastic proliferation of Langerhans cells which contain Birbeck granules by ultrastructural examination. Three major overlapping syndromes are recognized: eosinophilic granuloma, Letterer-Siwe disease, and Hand-Schuller-Christian disease. The clinical course is generally related to the number of organs affected at presentation. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8BDC24-88E8-D4D0-E040-BB89AD433258","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8BDC24-88F9-D4D0-E040-BB89AD433258","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-22","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"lch_post_best_response_kn","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the best response of","type":"Preferred Question Text","description":"What was the best response of Langerhans Cell Histiocytosis disease?","url":null,"context":"NHLBI"},{"name":"What was the best response to HSCT?","type":"Alternate Question Text","description":"What was the best response to HSCT?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADDABD7C-8F63-A79E-E040-BB89AD43539E","latestVersionIndicator":"Yes","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review. 2021-3-19 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}